Ingevity (NYSE:NGVT) CEO Sells $383,100.00 in Stock

Ingevity Corporation (NYSE:NGVTGet Free Report) CEO David Li sold 5,000 shares of the business’s stock in a transaction on Wednesday, August 12th. The stock was sold at an average price of $76.62, for a total transaction of $383,100.00. Following the completion of the transaction, the chief executive officer owned 135,636 shares of the company’s stock, valued at approximately $10,392,430.32. This trade represents a 3.56% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Ingevity Stock Up 1.6%

Shares of NYSE NGVT traded up $1.21 during mid-day trading on Friday, hitting $76.53. The company had a trading volume of 185,864 shares, compared to its average volume of 292,661. The company has a market capitalization of $2.63 billion, a PE ratio of 52.06 and a beta of 1.16. The company has a debt-to-equity ratio of 22.52, a current ratio of 1.61 and a quick ratio of 1.15. Ingevity Corporation has a 1-year low of $45.85 and a 1-year high of $79.29. The business’s 50-day simple moving average is $73.36 and its 200 day simple moving average is $71.61.

Ingevity (NYSE:NGVTGet Free Report) last released its earnings results on Wednesday, July 29th. The company reported $1.74 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.33 by $0.41. Ingevity had a return on equity of 284.70% and a net margin of 4.65%.The firm had revenue of $314.10 million during the quarter, compared to analyst estimates of $312.20 million. Ingevity has set its FY 2026 guidance at 5.000-5.450 EPS. On average, analysts predict that Ingevity Corporation will post 5.4 earnings per share for the current year.

Wall Street Analysts Forecast Growth

A number of analysts recently weighed in on NGVT shares. Weiss Ratings upgraded shares of Ingevity from a “sell (d-)” rating to a “hold (c-)” rating in a research note on Friday, July 31st. Wall Street Zen downgraded shares of Ingevity from a “strong-buy” rating to a “buy” rating in a research note on Saturday, August 1st. Two analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. Based on data from MarketBeat, Ingevity presently has a consensus rating of “Hold” and a consensus price target of $80.00.

Check Out Our Latest Analysis on Ingevity

Institutional Trading of Ingevity

Hedge funds and other institutional investors have recently bought and sold shares of the business. Global Retirement Partners LLC purchased a new stake in Ingevity during the 4th quarter worth about $27,000. Frazier Financial Advisors LLC acquired a new position in Ingevity during the second quarter worth approximately $37,000. Meeder Asset Management Inc. purchased a new stake in Ingevity in the fourth quarter valued at approximately $33,000. Kestra Advisory Services LLC purchased a new stake in Ingevity in the fourth quarter valued at approximately $47,000. Finally, Geneos Wealth Management Inc. boosted its holdings in shares of Ingevity by 85.8% in the second quarter. Geneos Wealth Management Inc. now owns 838 shares of the company’s stock valued at $36,000 after acquiring an additional 387 shares during the period. 91.59% of the stock is currently owned by institutional investors and hedge funds.

Ingevity Company Profile

(Get Free Report)

Ingevity Corporation, traded as NGVT, is a specialty chemicals and performance materials company headquartered in North Charleston, South Carolina. The company operates two primary business units: Performance Chemicals and Performance Materials. The Performance Chemicals segment produces and markets specialty chemicals derived largely from wood and other natural feedstocks, including rosin acids, tall oil fatty acids and esters, as well as specialty petroleum resins. These products serve a broad range of industries, including paper, adhesives, coatings, oilfield drilling and consumer goods.

The Performance Materials segment develops and manufactures activated carbon products and composites for applications such as automotive emissions control, industrial air and water purification, and spill containment.

See Also

Receive News & Ratings for Ingevity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ingevity and related companies with MarketBeat.com's FREE daily email newsletter.